StockDuty ← Dashboard Sep 16, 2026 03:29 PM ET
CatalystFDA/Bio

ROCKET PHARMA UPGRADED AT NEEDHAM AS FDA OKS PIVOTAL TRIAL DESIGN - SEEKINGALPHA

FDA approval of pivotal trial design drives Needham upgrade for Rocket Pharma.

FDA approval of pivotal trial design drives Needham upgrade for Rocket Pharma.
FDA approval of pivotal trial design drives Needham upgrade for Rocket Pharma. — impact context not separately stored; see What changed.
Sources